Silver Spring Benicar Injury Lawyers
Benicar® is a prescription medication that has proven popular for those that are trying to reduce or control hypertension (high blood pressure).
However, the US FDA (United States Food & Drug Administration) has recently announced mandatory changes in Benicar® labeling to include an increased risk of cardiovascular problems in diabetic users, while in 2013 it connected the use of Benicar® with the development of sprue-like enteropathy, a GI condition which causes severe diarrhea, malnutrition and dehydration.
Have you or someone that you love taken this prescription drug and suffered a serious side effect?
At the law offices of Goldberg Finnegan, our Benicar injury lawyers are currently investigating claims related to this hypertension drug and accepting inquiries from users that may have experienced side effects after its consumption.
How Can Filing a Lawsuit Help Me?
The medical bills, lost wages, and other expenses you've incurred as a result of your illness may be restored if you file a lawsuit against Benicar's manufacturer, Daiichi Sankyo, Inc.
Lawsuits have already been filed alleging Benicar manufacturer, Daiichi Sankyo, Inc. may have failed to warn healthcare professionals and consumers about the risks associated with Benicar. The FDA's most recent Safety Announcement highlights the importance of proper labeling when patient health is at risk.
Only an attorney can help you decide whether your Benicar claim is valid, but taking legal action can help you achieve the justice and compensation you deserve.
FDA Safety Announcement
In July 2013, the FDA announced Benicar would receive a label update to reflect the risk of sprue-like enteropathy. According to the FDA's drug safety communication, this GI disorder can cause symptoms that include severe, chronic diarrhea with substantial weight loss. The condition may take months or years to develop and may require hospitalization, the FDA noted.
On June 24, 2014, the FDA announced it would not be recalling Benicar, but that it will require Benicar's labeling to include language about the potential connection between cardiac events and this dangerous drug.
Its decision to do so is based on a ROADMAP (Randomized Olmesartan and Diabetes Microalbuminuria Prevention) study that was meant to see whether olmesartan could delay kidney damage in patients with Type 2 diabetes.
What the study found instead was that these patients had an increased risk of cardiovascular death compared to those who were given a placebo. While the risk of non-fatal heart attack was lower in olmesartan patients, the FDA has taken steps to alert the public of the link.
Contacting our Benicar Lawyers for Help Today
Choosing a lawyer to help guide you through the litigation process can be an important step when recovering from an injury.
At the law offices of Goldberg Finnegan, our personal injury lawyers have a proven track record of success and can provide the experience that is required to fully litigate your claim.
Our highly trained lawyers have numerous industry awards and accolades for their work protecting victims of medical malpractice and other serious person injuries and can help to explain the entire legal process in simple terms.
Whether you suffered from GI problems or lost a loved one to a heart attack or stroke, our Benicar lawyers are behind you every step of the way, advocating on your behalf.
We always fight for the maximum amount of compensation available to our clients, and you never pay us unless we win your case.